Form 8-K - Current report:
SEC Accession No. 0001493152-22-019997
Filing Date
2022-07-21
Accepted
2022-07-21 14:59:58
Documents
12
Period of Report
2022-07-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 30970
  Complete submission text file 0001493152-22-019997.txt   194756

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clcs-20220718.xsd EX-101.SCH 2968
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clcs-20220718_lab.xml EX-101.LAB 34240
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clcs-20220718_pre.xml EX-101.PRE 22365
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3159
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

EIN.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55413 | Film No.: 221096861
SIC: 2834 Pharmaceutical Preparations